THE TAPE

John B. Sanfilippo & SON

$60.63▲ +2.66%
Last close
Relative strength
14RS
of 99, against every stock▼ -14 on the month
Falling back
Caution
−19.9%
six months against the S&P 500
52-week range
−34.2%
from the high
$50.73$92.08
Setup
On no screen
No base, flag or squeeze in place tonight. What is and is not there
No report date on the calendar.
Growth FLATProof SHOWN
Quarter to Sep 24, revenue −4% on a year ago
Why it is on no screen

JBSS is off the screens on 3 checks.

A base has formed19.0 weeks, from 50.73 to 92.08.
Long enough to count19.0 weeks against 3 needed.
Shallow enough44.9% deep against 35% allowed.
Close to its pivot-34.2% from the pivot; listed down to -20%.
Relative strengthRS 14 against 70 needed.

Measured against the base-and-breakout thresholds. The other screens use their own numbers, so a name can miss here and still be a fair-looking chart.

Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
Support and resistance
Support below
None within the last 120 sessions
Resistance above
$65.74
+8.4% · tested 4× · last 18 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

John B. Sanfilippo & SON is not on any of the screens right now. Its relative strength rating is 14, and it sits in Sugar & Confectionery Products.

Against its industry
CautionBehind its industry over all three, in an industry that is not ahead of the S&P 500.
One month against the S&P 500
-6.3%
Three months against the S&P 500
-24.7%
Six months against the S&P 500
-19.9%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Peers
Same industry
Same theme
No themes — common and fine.
Catalyst roadmap
18
days
Ex-dividend in 18 days
Dec 4, 2026
  1. Ex-dividendconfirmedin 18d
    Ex-dividend date
    Dec 4, 2026
How it moves on earnings

On average 10.9% either way across its last 5 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$1.2B
-3.5% year on year
Operating margin
7.0%
gross 17.7%
Net margin
4.8%
Free cash flow
$30.4M
4.3% of market cap
Price to sales
0.61×
Price to earnings
12.6×

Twelve months to Sep 24, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Oct 28
Key takeaway
Profitable and cash generating; the question is growth.
Revenue
$288.1M
+2.7% QoQ · -3.5% YoY
Gross margin
17.0%
+1.3 pts QoQ
Net income
$13.2M
Positive
Free cash flow
$1.9M
Cash generating

What the numbers say

  • Revenue -3.5% year over year, +2.7% on the quarter
  • Good: Gross margin 17.0%, +1.3 points on the quarter
  • Good: Profitable: net income $13M, operating margin 6.7%
  • Good: Cash generating: operating cash flow $11M, free cash flow $2M
  • Net debt $41M · cash $2M
Revenue by quarter
Free cash flow
Net income
shares +0.8% in a year · net debt $40.8M

The desk’s own read

Flagged as drifting down since the report

Final read
Growth: FLAT · Economic proof: SHOWN
Key question: Can the cash generation hold as growth slows?
The next test is whether the quarter repeats.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

None of the tracked funds held or sold it in their latest filings.

Flagged by the market sweep
GappedTape · 2026-11-14
+5.1%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
New 52-week lowTape · 2026-11-03
2.4x vol
Mixed: stocks have outrun random stocks by 0.6% over three sessions, not consistently enough to call (746 cases over 51 nights). Against their own sector they have outrun by 0.2%.
Unusual volumeTape · 2026-11-03
3.7 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
Reported resultsFiling · 2026-10-31
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
New 52-week lowTape · 2026-10-31
2.4x vol
Mixed: stocks have outrun random stocks by 0.6% over three sessions, not consistently enough to call (746 cases over 51 nights). Against their own sector they have outrun by 0.2%.
Unusual volumeTape · 2026-10-31
4.7 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
GappedTape · 2026-10-30
-14.9%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Moved 5%+ down on earningsTape · 2026-10-30
-14.9% on earnings 2026-10-28
No measurable effect: stocks behave like random ones over the next three sessions (665 cases over 44 nights).

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Sanfilippo & Son (JBSS) Misses Q1 Earnings and Revenue EstimatesZacks Investment Research · 2026-10-28

Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.

Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

What analysts expect
Strong buy1
Buy1
Hold0
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray

No completed base to compare this one with yet.

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
John B. Sanfilippo & SON (JBSS) — The Tape